Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
  1. 4 Grant or award Director acquired 7,117 shares (grant or award)
  2. 4 Grant or award Director acquired 7,117 shares (grant or award)
  3. 4 Grant or award Director acquired 7,117 shares (grant or award)
  4. 4 Grant or award Director acquired 7,117 shares (grant or award)
  5. 4 Grant or award Director acquired 7,117 shares (grant or award)
  6. 4 Grant or award Director acquired 7,117 shares (grant or award)
  7. 4 Other acquisition Director acquired 208 shares (other)
  8. 4 Other disposition Director disposed of 930,901 shares (other)
  9. 4 Open-market sale Chief Data Officer sold 10,387 shares at $8.24 ($85,589)
  10. 4 Grant or award Chief Data Officer acquired 40,854 shares (grant or award)
  11. 4 Open-market sale Chief Data Officer sold 4,205 shares at $9.59 ($40,326)
  12. 4 Open-market sale Chief Scientific Officer sold 4,902 shares at $9.59 ($47,010)
  13. 4 Open-market sale General Counsel sold 4,902 shares at $9.59 ($47,010)
  14. 4 Open-market sale Chief Financial Officer sold 6,592 shares at $9.59 ($63,217)
  15. 4 Open-market sale Chief Executive Officer sold 11,992 shares at $9.59 ($115,003)
  16. 4 Open-market sale Chief Information Officer sold 4,902 shares at $9.59 ($47,010)
  17. 4 Planned sale Chief Scientific Officer sold 77,136 shares at an average $9.44 ($727,853)
  18. 4 Open-market sale Chief Executive Officer sold 38,899 shares at $9.37 ($364,484)
  19. 4 Open-market sale Chief Financial Officer sold 8,092 shares at $9.37 ($75,822)
  20. 4 Open-market sale Chief Scientific Officer sold 21,438 shares at $9.55 ($204,733)

Page 10 of 16 · 313 filings